A Comparison of the Real-Life Clinical Effectiveness of the Leading Licensed ICS/LABA Combination Inhalers in the Treatment for COPD

INTRODUCTION: The Fostair® 100/6 (BDP/FF) pressurized metered-dose inhaler, delivering an extrafine formulation, is licensed for asthma and COPD in the UK. However, its real-life effectiveness for COPD has not been evaluated. This study compared the clinical effectiveness of BDP/FF against other lic...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Int J Chron Obstruct Pulmon Dis
Hauptverfasser: Ming, Simon Wan Yau, Haughney, John, Ryan, Dermot, Small, Iain, Lavorini, Federico, Papi, Alberto, Singh, Dave, Halpin, David M G, Hurst, John R, Patel, Shishir, Ochel, Matthias, Kocks, Janwillem, Carter, Victoria, Hardjojo, Antony, Price, David B
Format: Artigo
Sprache:Inglês
Veröffentlicht: Dove 2020
Schlagworte:
Original Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7705280/
https://ncbi.nlm.nih.gov/pubmed/33273812
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S263745
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge